Overall, these data suggest that CD34+ progenitor/stem cell compartment usually harbors KD mutations in CP-CML, and these low level mutations are more likely to be detected in CD34+ cell population, as compared to MNC. The gene discussed is CD34; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.